Hormone replacement therapy (HRT)

Examples

Hormone replacement therapy (HRT) refers to the use of estrogen plus progestin for the treatment of perimenopausal symptoms. It is also commonly referred to as "opposed estrogen therapy."

Estrogen and progestin combinations (pills or tablets)

Generic NameBrand Name
conjugated estrogens/medroxyprogesteronePremplus
estradiol/norethindrone acetateFemHRT

Transdermal combination preparations (a patch placed on the skin that continuously releases estrogen and progestin)

Generic NameBrand Name
estradiol/norethindrone acetateEstracomb, Estalis, Estalis Sequi

Oral progestin (pills or tablets; used along with an estrogen-only preparation)

Generic NameBrand Name
medroxyprogesteroneProvera
micronized progesteronePrometrium
norethindroneMicronor, Norlutin

Progestin intrauterine device (IUD; used along with an estrogen-only preparation)

Generic NameBrand Name
levonorgestrelMirena

Estrogen-progestin hormone therapy, or HRT, is recommended for all women with a uterus who choose to take estrogen. Using estrogen without progestin greatly increases your risk of endometrial cancer. Taking progestin with estrogen eliminates this increased risk.1

How It Works

HRT increases the estrogen and progestin levels in your body. There are several standard hormone replacement therapy schedules, including continuous and cyclic along with higher-dose and low-dose.

Combining progestin with estrogen:

  • Protects against endometrial cancer (which can develop with estrogen-only therapy).
  • Is not needed for women who have no uterus.
  • May trigger monthly withdrawal bleeding when progestin is used periodically (such as in cyclic HRT).

Patch warning. Direct sunlight or high heat can increase, then lower, the amount of hormone released from a patch. This can give you a big dose at the time and leave less hormone for the patch to release later in the week. Avoid direct sunlight on the hormone patch. Also avoid using a tanning bed, heating pad, electric blanket, hot tub, or sauna while you are using a hormone patch.

Why It Is Used

The estrogen in hormone therapy is used by some post-menopausal women to increase estrogen levels. This helps prevent osteoporosis and perimenopausal symptoms, such as hot flashes and sleep problems.

But HRT slightly increases risks of some serious health problems. This means that in a small number of women, HRT is known to cause breast cancer, ovarian cancer, blood clots, or dementia. In women who are 10 or more years past menopause, using HRT slightly raises the risk of heart disease.2

The Society of Obstetricians and Gynaecologists of Canada (SOGC) recommends HRT for:

  • Short-term treatment of menopausal symptoms, at the lowest effective dose for as short a time as possible.3
  • Osteoporosis prevention and treatment, in select cases. Most experts recommend that HRT only be considered for women with significant risk of osteoporosis that may outweigh their risks of taking HRT.4 Women are now encouraged to consider all possible osteoporosis treatments and to compare their risks and benefits.5 For more information, see the topic Osteoporosis.

Who should not use HRT

You should not use HRT if you:

How Well It Works

HRT increases estrogen levels, which:6, 7

  • Helps prevent post-menopausal osteoporosis by slowing bone loss and promoting some increase in bone density.7
  • Reduces hot flashes, depression, and sleep problems in most, but not all, women.7, 8
  • Maintains the lining of the vagina, reducing irritation.
  • Increases skin collagen levels, which drop as estrogen levels naturally decrease. Collagen is responsible for the stretch in skin and muscle.
  • Reduces the risk of dental problems, such as tooth loss and gum disease.
  • May slightly lower the risk of colon cancer.6 (This is based on one study.)

Side Effects

Risks of hormone replacement therapy

Hormone replacement therapy was part of a large set of clinical trials called the Women's Health Initiative (WHI). The HRT portion of these trials showed a small increase in the rate of breast cancer among the women taking a combination of 0.625 mg of estrogen plus 2.5 mg of progestin daily. WHI data has also shown an increased rate of cardiovascular disease and dementia with HRT use.

  • Within the first 2 years, HRT use slightly increased the number of women with blood clots in the lungs (pulmonary embolism) and legs (deep vein thrombosis). This risk increased in all healthy post-menopausal women, regardless of risk factors.9
  • During the second year, HRT use began to slightly increase heart attack and stroke risk in all healthy post-menopausal women, regardless of risk factors. Early signs of heart disease first became apparent during the first year of use.9, 10 Heart disease risk may differ for younger menopausal women.11, 12
  • After 1 year, HRT use increased the number of abnormal mammograms by approximately 4% per year. Daily estrogen-progestin increased breast density compared with estrogen alone or placebo. Although the abnormal mammograms required additional medical evaluation, they were not linked to an early increase in breast cancer. Studies are ongoing to learn more about breast density change from HRT.13
  • After 4 years of use, HRT-related breast cancers first became apparent. The number of HRT-related breast cancers increased with each additional year of HRT use. Women taking HRT generally had larger, more advanced tumours than women who developed breast cancer while taking placebo treatment.6 (Some of these cancers, however, may respond more favourably to treatment.)14
  • After 4 years, HRT use slightly increased the incidence of Alzheimer’s disease and other dementias in women ages 65 and older. HRT does not provide protection from dementia or cognitive impairment, as was previously believed.15 (Most of the women in this study started HRT several years after menopause, when Alzheimer's risk naturally increases. Therefore, experts do not yet know whether Alzheimer's risk is the same for younger women who use short-term HRT starting at menopause.)

Experts do not yet know whether lower-dose, shorter-term HRT reduces or eliminates these risks.

Serious health events caused or prevented by HRT, per 1,000 women (estrogen 0.625 mg plus progestin 2.5 mg):16
Health eventAfter 2 years of HRT useAfter 5.2 years of HRT use
Blood clots (venous thromboembolism) 6 more*9 more
Coronary artery disease3 more **4 more
Breast cancerNo change***4 more
Stroke1 more****4 more
Colorectal cancerNo change

3 fewer#

Hip fractures1 fewer2 fewer
DeathNo changeNo change

* Risk is greatest during the first 2 years of use.

** Signs develop as early as the first year of use.

*** First noted after 4 years of use.

**** First noted after 1 year of use.

# Benefit noted after 3 years of use.

These average increased risks are relatively low in the general population of post-menopausal women. Your personal risk that hormone therapy may stimulate breast cancer, cardiovascular problems, blood clots, or neurological changes may be significantly lower or higher, depending on your risk factors. Not all possible risk factors are known.

Estrogen side effects

Side effects that can occur with all forms of estrogen but are more frequent with oral estrogen include:

  • Irregular vaginal bleeding.
  • Headaches.
  • Nausea.
  • Vaginal discharge.
  • Fluid retention.
  • Weight gain.
  • Breast tenderness.
  • Spotting or darkening of the skin, particularly on the face.
  • Asthma. Newly diagnosed asthma appears to be more common among women taking HRT or estrogen-alone (ERT) than women who are not. (Estrogen is thought to be a factor that causes or worsens asthma across the lifespan.)17
  • Gallstones. Women who use estrogen replacement therapy are more likely to have gallstones that cause symptoms than women who do not use ERT. (High estrogen levels are linked to gallbladder disease.)
  • Rarely, an increased growth of pre-existing uterine fibroids or a worsening of endometriosis.

In addition, the estrogen patch (transdermal estrogen) may cause skin irritation.

Some of these side effects, such as headaches, nausea, fluid retention, weight gain, and breast tenderness, may go away after a few weeks of use.

Progestin side effects

The side effects of progestin often cause women to stop using hormone replacement therapy (HRT). Adjusting the progestin dose, changing the dosing schedule, or changing the type of progestin may reduce side effects. The progestin intrauterine device (IUD) reduces or eliminates side effects that are common with oral progestin.1

Progestin side effects include:

  • Mood changes, such as anxiety, irritability, or depression.
  • Headache.
  • Breast pain or tenderness.
  • Abdominal pain or bloating (distention).
  • Dizziness or drowsiness.
  • Diarrhea.
  • Vaginal discharge.

Cyclic progestin (taken 10 to 14 days per month) is more likely to cause:

  • Premenstrual-like symptoms, such as bloating, cramping, breast tenderness, nausea, and depression.
  • Monthly withdrawal bleeding.

The combination transdermal patch may cause skin irritation.

See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)

What To Think About

If you have been taking HRT, talk with your health professional about your reasons for taking it. Are you taking it to help with perimenopausal symptoms or for long-term health reasons? Consider changing to another treatment, depending on the problem you are using HRT to treat. If HRT seems like the best choice for you, plan to use the lowest possible effective dose.

If you are unable to tolerate the side effects of progestin in hormone replacement therapy and you have not had a hysterectomy, try non-hormonal treatment options.

Some women use estrogen-only therapy (ERT) if testing does not show abnormalities of the lining of the uterus (endometrium). However, because this greatly increases your risk of uterine cancer, health professionals don't recommend taking estrogen alone. If you do take estrogen without progestin, you must have regular checks for precancerous changes of the endometrium. This means an annual pelvic examination along with an annual endometrial biopsy or transvaginal ultrasound.

The British Million Women Study has confirmed the Women's Health Initiative findings and has provided more information about estrogen, progestin, and breast and endometrial cancers.18 This is important information for women deciding whether to take estrogen without progestin, as described above.

When given with a skin patch, estrogen-progestin enters the bloodstream directly, without passing through the liver. The estrogen and progestin in pills must be processed by the liver before entering the bloodstream. This is why women with liver or gallbladder disease can usually use a patch form of HRT.

Complete the new medication information form (PDF)Click here to view a form.(What is a PDF document?) to help you understand this medication.



Author: Kathe Gallagher, MSW
Carrie Henley
Last Updated: August 4, 2006
Medical Review: Joy Melnikow, MD, MPH - Family Medicine
Tom Bailey, MD - Family Medicine
Carla J. Herman, MD, MPH - Internal Medicine

© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

Click here to learn about Healthwise
Click here to learn about Healthwise
Topic Contents
 Examples
 How It Works
 Why It Is Used
 How Well It Works
 Side Effects
 What To Think About
 References